Register today to unlock Valuecruncher

Choose a username
Your email address
Choose a password
Confirm password
Choose your membership
1 year account US$89 US$49
Lifetime account US$299 US$199
Name on card *
Credit card number *
Credit card expiry *
or Cancel
Our terms & conditions and privacy policy

Unlimited access to all companies
Save your own valuations
Comparison + DCF analysis for S&P500, FTSE350 and others

If you have already registered, please login

Acrux Limited (ACR)

Register today to unlock Valuecruncher and get unlimited access

Get unlimited access to all compartors and data
Save and share valuations as well as comment on others
Alter and save your favourite comparator companies

Already registered? Please login now

Dollar

Point

Implied share price

Sell Overvalued by 85.1%

5% margin of safety What's this?

EV / EBITDA Use Average	ACR Acrux Limited	SNY Sanofi SA (ADR) Change	DNA Genentech, Inc. Change	GILD Gilead Sciences, Inc. Change	AMGN Amgen, Inc. Change
12.67	116.89	6.52	17.08	21.38	9.0
All amounts in millions from last financial year
Implied Share Price	$0.58	$112.81	$71.28	$31.45	$148.48
Market Cap	646	145,886	100,042	85,313	78,395
Net Debt	-30	8,094	-3,369	6,361	2,468
Enterprise Value (EV)	615	80,938	96,673	91,674	80,863
Revenue	10	35,957	13,418	9,702	17,265
EBITDA	5	12,422	5,661	4,288	8,985
Percent	49.2 %	34.5 %	42.2 %	44.2 %	52.0 %
EBIT	4	7,825	5,069	4,010	7,500
Percent	45.9 %	21.8 %	37.8 %	41.3 %	43.4 %
Balance Sheet
Total Assets	58	100,407	21,787	21,239	54,298
Total Liabilities	5	43,069	6,116	11,930	35,238
Shareholders Equity	53	57,338	15,671	9,309	19,060.0

Comments

No comments yet. Login to comment.